Purchase Order 75D30124P18550
Award Date 2/21/24
Potential Completion Date 3/1/25
Potential Value $6.8K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The CDC Pittsburgh awarded a purchase order to Roche Diagnostics Corporation for a Roche Service Agreement valued at $150,782.40 on April 1, 2023, with ultimate completion on March 31, 2027. No set-aside was used. Work is performed in Atlanta, Georgia. The purchase order is issued under firm fixed-price terms and covers diagnostic equipment and related service provisions supporting CDC clinical laboratory operations.</p>
- This is a $97,000.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment. The contract, titled "MAGNA 96", has an ultimate completion date of November 30, 2015 and does not have a set-aside designation. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment,...
- <p>The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a purchase order to Roche Diagnostics Corporation for $108,800.00 on March 27, 2023, for preventative maintenance under firm fixed-price terms with an ultimate completion date of March 31, 2028. Work is performed at Castleton, Indiana. No set-aside applies to this order.</p>
- <p>CDC Pittsburgh awarded a purchase order to Roche Diagnostics Corporation for $130,151.30 on September 12, 2026, with an ultimate completion date of September 11, 2027. The order carries firm fixed-price terms and no set-aside.</p> <p>Performance occurs in Atlanta, Georgia. The purchase order covers in vitro diagnostic equipment, reagents, laboratory instruments, or associated medical products supplied under Roche Diagnostics' commercial catalog and GSA Schedule pricing.</p>
- This $52,252 firm fixed price purchase order contract was awarded to Roche Diagnostics Corporation by the Centers for Disease Control and Prevention (CDC) on September 2, 2022. The contract is for MAGNAPURE 24, a diagnostic product, with a performance period ending on August 24, 2023. Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is a manufacturer and distributor of in vitro diagnostic products, laboratory instruments, and associated medical supplies. This contract...
- <p>The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a purchase order to Roche Diagnostics Corporation for the ROCHE COBAS 5800 with a ceiling value of $150,000.00 on September 15, 2023. The order is firm fixed price with no set-aside designation. Performance is at Castleton, Indiana. The ultimate completion date is November 14, 2023.</p>
- Roche Diagnostics Corporation was awarded a firm fixed price purchase order by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh. The award, valued at two hundred thirty-seven thousand seven hundred forty-one dollars and sixty cents ($237,741.60), is for the product "MAGNA PURE 96" and has a completion date of October 15, 2020. The place of performance is Castleton, Indiana. No set-aside designation was used for this contract. Roche...
- The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $90,000 firm fixed price purchase order to Roche Diagnostics Corporation. Under this contract, Roche will deliver MAGNA PURE 96 INSTRUMENTS to the CDC location in Castleton, Indiana by September 20, 2023 to support the agency's disease prevention and health promotion efforts. As one of the largest government contractors in the medical device sector, Roche will leverage existing...
- This $90,000.00 firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation for MAGNA PURE 96 products. The contract has no set-aside designation and has a completion date of July 23, 2022. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. They have previously received prime contract and subcontract awards from various federal...
- This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is for the purchase of MOVE MAGNA PURE 24 EQUIPMENT. The $6,000 firm fixed price contract was awarded on June 10, 2024 by the Centers for Disease Control and Prevention (CDC) in Pittsburgh, a civilian federal agency. There is no set-aside designation for this award. Roche Diagnostics is a global provider of in vitro diagnostics, reagents, laboratory instruments, and associated products and...
The CDC Pittsburgh awarded a purchase order to Roche Diagnostics Corporation for Magnapure 24 Service on February 21, 2024, with a ceiling value of $6,760.00 and firm fixed-price terms. Work is performed in Atlanta, Georgia, with an ultimate completion date of March 1, 2025. The order procures diagnostic service support for Magnapure equipment.
Generated 7/9/26, 11:52 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 2/20/24 |